journal article·2022-10-05Open access

Charge-Converting Nanoemulsions as Promising Retinal Drug and Gene Delivery Systems

Nguyet-Minh Nguyen Le, Sarah Zsák, Bao Le-Vinh, Julian David Friedl, Gergely Kali, Patrick Knoll, Hartwig Wolfram Seitter, Alexandra Koschak, Andreas Bernkop-Schnürch

ACS Applied Materials & Interfaces· Volume 14· Issue 39

Abstract

AIM: This study aimed to develop phosphatase-responsive ζ potential converting nanocarriers utilizing polyphosphate-coated cell-penetrating peptide (CPP)-decorated nanoemulsions (NEs) as a novel gene delivery system to retinal cells. METHODS: Poly-l-lysine (PLL) was first conjugated with oleylamine (OA) only at its carboxylic end to form the amphiphilic PLL-oleylamine (PLOA) conjugate. Afterward, NEs were loaded with PLOA prior to being coated with tripolyphosphate (TPP) to generate PLOA/TPP NEs. A plasmid containing a reporter gene for green fluorescent protein plasmid (pGFP) was complexed with cationic surfactants forming hydrophobic ion pairs that were loaded in the oily core of NEs. Phosphate removal, ζ potential conversion, and cytotoxicity of the system were evaluated. Cellular uptake and transfection efficiency were investigated in 661W photoreceptor-like cells via microscopic analysis, fluorescence spectroscopy, and flow cytometry. RESULTS: Dephosphorylation of PLOA/TPP NEs triggered by alkaline phosphatase (ALP) resulted in the exposure of positive amine groups on the surface of NE droplets and a notable conversion of the ζ potential from -22.4 to +8.5 mV. Cellular uptake of PLOA/TPP NEs performed on 661W photoreceptor-like cells showed a 3-fold increase compared to control NEs. Furthermore, PLOA/TPP NEs also showed low cytotoxicity and high transfection efficacy with ∼50% of cells transfected. CONCLUSIONS: Polyphosphate-coated CPP-decorated NEs triggered by ALP could be a promising nanosystem to efficiently deliver drugs and genetic materials to photoreceptor-like cells and other retinal cells for potential treatments of retinal diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria

Center for Chemistry and Biomedicine, Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria

Funding

Universit?t Innsbruck · Austrian Science Fund

References (48)

Show source-provided references
1. 10.1016/J.BIOMATERIALS.2013.06.00210.1016/J.BIOMATERIALS.2013.06.002 ↗
2. 10.1016/J.BIOMATERIALS.2016.03.00410.1016/J.BIOMATERIALS.2016.03.004 ↗
3. 10.2174/156652321766617111617004010.2174/1566523217666171116170040 ↗
4. 10.1016/J.GIM.2021.10.01310.1016/J.GIM.2021.10.013 ↗
5. 10.1016/j.drudis.2019.03.00410.1016/j.drudis.2019.03.004 ↗
6. 10.1007/s11095-008-9694-010.1007/s11095-008-9694-0 ↗
7. 10.1002/wnan.147310.1002/wnan.1473 ↗
8. 10.1007/S11095-015-1717-Z/FIGURES/510.1007/S11095-015-1717-Z/FIGURES/5 ↗
9. 10.1167/IOVS.05-016510.1167/IOVS.05-0165 ↗
10. 10.1016/J.BIOMATERIALS.2012.01.03010.1016/J.BIOMATERIALS.2012.01.030 ↗
11. 10.1517/17425247.2014.92786410.1517/17425247.2014.927864 ↗
12. 10.1016/J.ADDR.2018.01.00810.1016/J.ADDR.2018.01.008 ↗
13. 10.1023/A:102323853050410.1023/A:1023238530504 ↗
14. 10.1007/S11095-008-9745-6/FIGURES/610.1007/S11095-008-9745-6/FIGURES/6 ↗
15. 10.1016/J.JCONREL.2013.01.01810.1016/J.JCONREL.2013.01.018 ↗
16. 10.1021/JA309812Z/SUPPL_FILE/JA309812Z_SI_001.PDF10.1021/JA309812Z/SUPPL_FILE/JA309812Z_SI_001.PDF ↗
17. 10.1186/S11671-018-2728-610.1186/S11671-018-2728-6 ↗
18. 10.1039/C6CS00636A10.1039/C6CS00636A ↗
19. 10.1016/j.ijpharm.2015.01.04110.1016/j.ijpharm.2015.01.041 ↗
20. 10.1002/ADTP.20210021910.1002/ADTP.202100219 ↗
21. 10.1073/pnas.29.6.17610.1073/pnas.29.6.176 ↗
22. 10.1016/0012-1606(82)90067-710.1016/0012-1606(82)90067-7 ↗
23. 10.1242/dev.82.1.24110.1242/dev.82.1.241 ↗
24. 10.1007/BF0168736610.1007/BF01687366 ↗
25. 10.1007/S11095-008-9756-310.1007/S11095-008-9756-3 ↗
26. 10.1016/J.BIOADV.2022.21276710.1016/J.BIOADV.2022.212767 ↗
27. 10.1016/J.COLSURFB.2010.05.02610.1016/J.COLSURFB.2010.05.026 ↗
28. 10.1016/J.JCONREL.2015.04.01310.1016/J.JCONREL.2015.04.013 ↗
29. 10.1016/J.CEJ.2022.13511610.1016/J.CEJ.2022.135116 ↗
30. 10.1016/S0167-4838(01)00193-510.1016/S0167-4838(01)00193-5 ↗
31. 10.1016/j.ejpb.2019.09.01210.1016/j.ejpb.2019.09.012 ↗
32. 10.1016/j.jcis.2020.12.01910.1016/j.jcis.2020.12.019 ↗
33. 10.1136/bjo.35.3.14910.1136/bjo.35.3.149 ↗
34. 10.1167/tvst.9.1.210.1167/tvst.9.1.2 ↗
35. 10.1089/jop.1997.13.44510.1089/jop.1997.13.445 ↗
36. 10.1016/j.ejpb.2021.03.01210.1016/j.ejpb.2021.03.012 ↗
37. 10.1016/j.jcis.2021.01.02510.1016/j.jcis.2021.01.025 ↗
38. 10.1016/j.ab.2005.07.03310.1016/j.ab.2005.07.033 ↗
39. 10.3389/fphar.2020.0069710.3389/fphar.2020.00697 ↗
40. 10.1016/j.jconrel.2018.06.02310.1016/j.jconrel.2018.06.023 ↗
41. 10.1016/j.nano.2017.02.00710.1016/j.nano.2017.02.007 ↗
42. 10.1007/BF0263428310.1007/BF02634283 ↗
43. 10.1016/s0168-3659(99)00158-310.1016/s0168-3659(99)00158-3 ↗
44. 10.1002/jgm.53910.1002/jgm.539 ↗
45. 10.3390/MOLECULES2310256410.3390/MOLECULES23102564 ↗
46. 10.1080/10717544.2018.151006510.1080/10717544.2018.1510065 ↗
47. 10.1007/S10529-016-2064-910.1007/S10529-016-2064-9 ↗
48. 10.1038/MTNA.2016.810.1038/MTNA.2016.8 ↗